M&A Deal Summary

Apex Laboratories International Acquires Apex Laboratories International

On July 11, 2012, Apex Laboratories International acquired life science company Apex Laboratories International from Huron Capital

Acquisition Highlights
  • This is Apex Laboratories International’s 1st transaction in the Life Science sector.
  • This is Apex Laboratories International’s 1st transaction in the United States.
  • This is Apex Laboratories International’s 1st transaction in Delaware.

M&A Deal Summary

Date 2012-07-11
Target Apex Laboratories International
Sector Life Science
Buyer(s) Apex Laboratories International
Sellers(s) Huron Capital
Deal Type Add-on Acquisition

Target

Apex Laboratories International

Delaware, United States
Through its operating company Labstat International, Apex is a leading international contract research organization focused on chemistry, biological and standards testing for commercial and governmental concerns. The firm provides a broad array of chemical analysis services through state-of-the-art laboratories, including method development, clinical trial management programs and product research & development support.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Apex Laboratories International

Delaware, United States

Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Through its operating company Labstat International, Apex is a leading international contract research organization focused on chemistry, biological and standards testing for commercial and governmental concerns. The firm provides a broad array of chemical analysis services through state-of-the-art laboratories, including method development, clinical trial management programs and product research & development support.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Delaware) 1 of 1
Country (United States) 1 of 1
Year (2012) 1 of 1

Seller(S) 1

SELLER

Huron Capital

Detroit, Michigan, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 1.8B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Huron Capital Partners is a private equity firm that seeks to acquire or recapitalize niche manufacturers, value-added distributors and specialty service companies. Prospective transaction situations include management buyouts, corporate spin-offs, recapitalizations, family successions and consolidations. Huron prefers opportunities located in the US and Canada. Target companies typically have revenues between $20 and $200 million and EBITDA of at least $5 million. Huron can commit up to $10 million and $50 million of equity capital per transaction. Huron Capital Partners was formed in 1999 and has offices in Detroit, Michigan and Ontario, Canada.


DEAL STATS #
Overall 15 of 35
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 7 of 13
State (Delaware) 1 of 1
Country (United States) 15 of 32
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-06-18 Bloomer Plastics

Bloomer, Wisconsin, United States

Bloomer Plastics, Inc. is a manufacturer of custom cast embossed and blown film structures across a range of end markets.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-09 LeadingResponse

Tampa, Florida, United States

LeadingResponse is client acquisition and lead generation specialist to professional service firms. LeadingResponse offers technology-enabled, data-driven client acquisition services to professional services end markets. LeadingResponse was founded in 1995 and is based in Tampa, Florida and with operations in Plano, Texas.

Buy -